An overrepresentation of rare missense and protein truncating SMAD6 variants was also reported for CHD patients without PAH, in particular in those with bicuspid aortic valve and thoracic aortic aneurysms10. This evidence concerns the gene SMAD6 and pulmonary arterial hypertension.